Developer docs
API playgroundTry for free, no card

Search company profiles

BioIntegral Surgical

Full company profile

uuid002nn4z

Namestring
BioIntegral Surgical
Legal namestring
BioIntegral Surgical Inc.
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMississauga, Canada
HQ citystring
Mississauga
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cardiovascular implants, biological implants, pediatric cardiac surgery, biocompatible medical devices, critical care implants
Industry2 codes
1Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)
CodeHLAHAFAHPrimaryYes
2Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
CodeHLAAAGABPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Cardiovascular Implants
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components6 values
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BioIntegral Surgical Inc. researches and manufactures all-biological cardiovascular implants intended for critical care pediatric and adult patients. The implants are designed to balance durable designs, quick implantation, and biocompatible materials, while applying overkill sterility methods aimed at eliminating the compromises and shortcomings of alternative cardiovascular implant products.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

BioIntegral Surgical Inc. offers all-biological cardiovascular implants designed for critical care pediatric and adult patients. The company focuses on developing devices that balance durable designs, quick implantation, and biocompatible materials while aiming to enhance patient outcomes and reduce complications. The source material does not enumerate specific named products or modules - only the general category of cardiovascular implants is mentioned.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Labcor is a Brazil-based manufacturer of biologic heart valves and vascular grafts, an emerging player focused on tissue-engineered cardiac implants that competes with BioIntegral's all-biological positioning.

TypeBroad incumbent
Description

Getinge offers a broad portfolio of cardiac surgery and perfusion products including vascular grafts, a broad incumbent serving the same cardiac surgery customer base as BioIntegral.

TypeBroad incumbent
Description

Boston Scientific's cardiovascular division covers structural heart and heart failure devices, a broad incumbent competing with newer entrants like BioIntegral in surgical implant indications.

TypeBroad incumbent
Description

Medtronic's Cardiac Surgery division offers heart valves, surgical ablation, and cannulae/grafts used in cardiac surgery — a broad incumbent with overlapping cardiovascular implant capabilities to BioIntegral Surgical.

TypeDirect peer
Description

Gore Medical is the leading manufacturer of expanded ePTFE vascular grafts and stent-grafts, a direct peer in biologic/synthetic cardiovascular graft implants used in cardiac and vascular surgery.

TypeBroad incumbent
Description

Edwards Lifesciences is a global leader in heart valves and critical care cardiovascular devices, an established incumbent with broader portfolio but overlapping surgical implant focus to BioIntegral Surgical.

TypeDirect peer
Description

Artivion is a tissue-based and mechanical cardiovascular implant company (heart valves, vascular grafts, patches), directly comparable to BioIntegral's focus on all-biological cardiovascular implants for cardiac surgery.

TypeDirect peer
Description

Terumo Cardiovascular supplies a full line of products for cardiopulmonary bypass and cardiac surgery including vascular grafts and patches, directly comparable to BioIntegral's biologic cardiovascular implants.

TypeBroad incumbent
Description

LivaNova's Cardiac Surgery business produces heart valves, cannulae, and surgical accessories used in cardiac surgery, an established player whose portfolio intersects BioIntegral's biologic implant focus.

TypeBroad incumbent
Description

Abbott's cardiovascular portfolio spans heart valves, vessel closure, and structural heart devices; a broad incumbent with overlapping cardiac implant categories where BioIntegral Surgical operates.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioIntegral Surgical

Cardiovascular Implantsbiointegral-surgical.com

BioIntegral Surgical firmographics

Firmographics
Name
BioIntegral Surgical
Legal name
BioIntegral Surgical Inc.
Website
https://biointegral-surgical.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

BioIntegral Surgical industry classification

Industry
Product category
Cardiovascular Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)
akta.pro secondary industry
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)

Keywords

  • Cardiovascular implants
  • Biological implants
  • Pediatric cardiac surgery
  • Biocompatible medical devices
  • Critical care implants

Where BioIntegral Surgical is headquartered

Location

Headquarters

HQ city
Mississauga
HQ country
Canada
HQ region
North America

Markets served

BioIntegral Surgical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Others

Marketing channels1 record

BioIntegral Surgical product offering

Product offering

Core offering

BioIntegral Surgical Inc. researches and manufactures all-biological cardiovascular implants intended for critical care pediatric and adult patients. The implants are designed to balance durable designs, quick implantation, and biocompatible materials, while applying overkill sterility methods aimed at eliminating the compromises and shortcomings of alternative cardiovascular implant products.

Product overview

BioIntegral Surgical Inc. offers all-biological cardiovascular implants designed for critical care pediatric and adult patients. The company focuses on developing devices that balance durable designs, quick implantation, and biocompatible materials while aiming to enhance patient outcomes and reduce complications. The source material does not enumerate specific named products or modules - only the general category of cardiovascular implants is mentioned.

Differentiator

Problem solved

Functional benefit

Companies that use BioIntegral Surgical

Customer profile

Segments2 records

Ideal customer profiles1 record

BioIntegral Surgical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BioIntegral Surgical partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights1 record

BioIntegral Surgical competitors and assessment

Company assessment

Emerging players

  • Labcor Laboratórios Ltda: Labcor is a Brazil-based manufacturer of biologic heart valves and vascular grafts, an emerging player focused on tissue-engineered cardiac implants that competes with BioIntegral's all-biological positioning.

Broad incumbents

  • Getinge (Cardiac Surgery): Getinge offers a broad portfolio of cardiac surgery and perfusion products including vascular grafts, a broad incumbent serving the same cardiac surgery customer base as BioIntegral.
  • Boston Scientific (Cardiovascular): Boston Scientific's cardiovascular division covers structural heart and heart failure devices, a broad incumbent competing with newer entrants like BioIntegral in surgical implant indications.
  • Medtronic: Medtronic's Cardiac Surgery division offers heart valves, surgical ablation, and cannulae/grafts used in cardiac surgery — a broad incumbent with overlapping cardiovascular implant capabilities to BioIntegral Surgical.
  • Edwards Lifesciences: Edwards Lifesciences is a global leader in heart valves and critical care cardiovascular devices, an established incumbent with broader portfolio but overlapping surgical implant focus to BioIntegral Surgical.
  • LivaNova (Cardiac Surgery): LivaNova's Cardiac Surgery business produces heart valves, cannulae, and surgical accessories used in cardiac surgery, an established player whose portfolio intersects BioIntegral's biologic implant focus.
  • Abbott (Cardiovascular): Abbott's cardiovascular portfolio spans heart valves, vessel closure, and structural heart devices; a broad incumbent with overlapping cardiac implant categories where BioIntegral Surgical operates.

Direct peers

  • W. L. Gore & Associates (Gore Medical): Gore Medical is the leading manufacturer of expanded ePTFE vascular grafts and stent-grafts, a direct peer in biologic/synthetic cardiovascular graft implants used in cardiac and vascular surgery.
  • Artivion (formerly CryoLife): Artivion is a tissue-based and mechanical cardiovascular implant company (heart valves, vascular grafts, patches), directly comparable to BioIntegral's focus on all-biological cardiovascular implants for cardiac surgery.
  • Terumo Cardiovascular: Terumo Cardiovascular supplies a full line of products for cardiopulmonary bypass and cardiac surgery including vascular grafts and patches, directly comparable to BioIntegral's biologic cardiovascular implants.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

BioIntegral Surgical social profiles

Digital presence

BioIntegral Surgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioIntegral Surgical leadership team

Management profile

Number of profiles

BioIntegral Surgical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioIntegral Surgical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioIntegral Surgical

What does BioIntegral Surgical do?

BioIntegral Surgical Inc. researches and manufactures all-biological cardiovascular implants intended for critical care pediatric and adult patients. The implants are designed to balance durable designs, quick implantation, and biocompatible materials, while applying overkill sterility methods aimed at eliminating the compromises and shortcomings of alternative cardiovascular implant products.

Is BioIntegral Surgical a public or private company?

BioIntegral Surgical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BioIntegral Surgical founded?

BioIntegral Surgical was founded in 2019. It employs 11 to 50 people.

Where is BioIntegral Surgical based?

BioIntegral Surgical is headquartered in Mississauga, Canada, in the North America region.

Who are BioIntegral Surgical's main competitors?

Labcor Laboratórios Ltda is listed as an emerging player. Broad incumbents are Getinge (Cardiac Surgery), Boston Scientific (Cardiovascular), Medtronic, Edwards Lifesciences, LivaNova (Cardiac Surgery) and Abbott (Cardiovascular). Direct peers are W. L. Gore & Associates (Gore Medical), Artivion (formerly CryoLife) and Terumo Cardiovascular.

Does BioIntegral Surgical have an API?

No public API is recorded for BioIntegral Surgical.

What industry is BioIntegral Surgical in?

BioIntegral Surgical's product category is Cardiovascular Implants. Its primary akta.pro industry code is HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts), with a secondary code of HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales